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Background
Hydrostatic lung edema is a characteristic complication of
acute left-sided ventricular or valvular heart failure that if
untreated has a high mortality due to the resulting respi-
ratory failure. Traditionally, formation of hydrostatic lung
edema has been attributed to an imbalance of Starling
forces, i.e. transcapillary hydrostatic and oncotic pressure
in the pulmonary circulation resulting in interstitial and
finally, alveolar edema. Yet, mechanosensitive cell
responses may play a critical regulatory role in this sce-
nario.
Results
In isolated perfused rat and mouse lungs, we have identi-
fied lung capillary endothelial and alveolar epithelial
responses relevant to the pathogenesis of cardiogenic lung
edema. Hydrostatic stress causes influx of Ca2+  into
endothelial cells via mechanosensitive cation channels of
the vanilloid-type transient receptor potential (TRPV)
family. The endothelial Ca2+ influx increases lung microv-
ascular filtration coefficient (Kf) via a myosin light chain
kinase-dependent mechanism, thus increasing lung
microvascular permeability and promoting edema forma-
tion. Yet simultanesouly, Ca2+ influx stimulates endothe-
lial formation of NO which attenuates endothelial Ca2+
influx and permeability increase by a cGMP-dependent
inhibition of mechanosensitive TRPV channels. Hence,
endothelial NO formation limits the hydrostatic stress-
induced increase in lung microvascular permeability via a
negative feedback loop. A similar protective mechanism
of NO seems to apply for the induction of permeability-
type lung edema by platelet-activating factor (PAF), which
induces lung edema formation by stimulating endothelial
Ca2+ influx via cation channels of the canonical-type tran-
sient receptor potential (TRPC) family and simultane-
ously blocking endothelial NO formation via a acid
sphingomyelinase-dependent mechanism.
Nitric oxide generated by lung microvascular endothelial
cells in response to lung hydrostatic stress also serves as
intercompartmental signal to epithelial cells outlining the
adjacent alveolar space. Endothelial-derived NO impairs
alveolar fluid clearance, a protective mechanism driven
primarily by epithelial ion transport via amiloride-sensi-
tive Na+ channels and the Na+, K+-ATPase. Over and above
that, endothelial-derived NO reverses the direction of
transalveolar chloride transport, thus stimulating active
alveolar fluid secretion which can be blocked by inhibi-
tors of Na+, K+-ATPase, cystic fibrosis transmembrane con-
ductance regulator (CFTR) or the Na+, K+, 2Cl--
Cotransporter NKCC1.
Conclusion
The presented data demonstrate that hydrostatic lung
edema is not simply the result of passive fluid fluxes as a
result of imbalanced Starling forces, but is largely regu-
lated by active cellular responses opening the potential for
new targeted strategies in the prevention and therapy of
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cardiogenic edema. NO and cGMP are identified as key
regulators in this scenario with both pro- and anti-edema-
tous effects.
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